Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndrome. (2010)
Attributed to:
Dissecting the cause of premature replicative senescence of Werner syndrome cells using selective chemical inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4155/fmc.09.163
PubMed Identifier: 21426186
Publication URI: http://europepmc.org/abstract/MED/21426186
Type: Journal Article/Review
Volume: 2
Parent Publication: Future medicinal chemistry
Issue: 2
ISSN: 1756-8919